Diagnosing coronary artery disease by sound analysis from coronary stenosis induced turbulent blood flow: diagnostic performance in patients with stable angina pectoris by Winther, Simon et al.
ORIGINAL PAPER
Diagnosing coronary artery disease by sound analysis
from coronary stenosis induced turbulent blood flow: diagnostic
performance in patients with stable angina pectoris
Simon Winther1,4 • Samuel Emil Schmidt2 • Niels Ramsing Holm1 •
Egon Toft3 • Johannes Jan Struijk2 • Hans Erik Bøtker1 • Morten Bøttcher4
Received: 9 April 2015 / Accepted: 22 August 2015 / Published online: 3 September 2015
 The Author(s) 2015. This article is published with open access at Springerlink.com
Abstract Optimizing risk assessment may reduce use of
advanced diagnostic testing in patients with symptoms
suggestive of stable coronary artery disease (CAD).
Detection of diastolic murmurs from post-stenotic coronary
turbulence with an acoustic sensor placed on the chest wall
can serve as an easy, safe, and low-cost supplement to
assist in the diagnosis of CAD. The aim of this study was to
evaluate the diagnostic accuracy of an acoustic test (CAD-
score) to detect CAD and compare it to clinical risk strat-
ification and coronary artery calcium score (CACS). We
prospectively enrolled patients with symptoms of CAD
referred to either coronary computed tomography or inva-
sive coronary angiography (ICA). All patients were tested
with the CAD-score system. Obstructive CAD was defined
as more than 50 % diameter stenosis diagnosed by quan-
titative analysis of the ICA. In total, 255 patients were
included and obstructive CAD was diagnosed in 63 patients
(28 %). Diagnostic accuracy evaluated by receiver oper-
ating characteristic curves was 72 % for the CAD-score,
which was similar to the Diamond–Forrester clinical risk
stratification score, 79 % (p = 0.12), but lower than
CACS, 86 % (p\ 0.01). Combining the CAD-score and
Diamond–Forrester score, AUC increased to 82 %, which
was significantly higher than the standalone CAD-score
(p\ 0.01) and Diamond–Forrester score (p\ 0.05).
Addition of the CAD-score to the Diamond–Forrester score
increased correct reclassification, categorical net-reclassi-
fication index = 0.31 (p\ 0.01). This study demonstrates
the potential use of an acoustic system to identify CAD.
The combination of clinical risk scores and an acoustic test
seems to optimize patient selection for diagnostic
investigation.
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Introduction
In patients presenting with symptoms suggestive of stable
angina pectoris, several diagnostic strategies can be used to
obtain a correct diagnosis. Primary clinical risk stratifica-
tion, e.g. the updated Diamond–Forrester score, is often
performed for patient selection to non-invasive imaging or
invasive coronary angiography [1]. However, the growing
concern regarding increasing health expenses has increased
the need for cost-effective diagnostic strategies for diag-
nosing coronary artery disease (CAD).
The detection of diastolic murmurs from post-stenosis
coronary turbulence reported already in the 1960s was
proposed for safe, cost-effective, and easy non-invasive
evaluation of patients with suspected CAD [2]. Advances
in computer and acoustic technology have facilitated the
automated detection and analysis of diastolic heart sounds
from which a risk assessment of CAD is calculated. Several
research groups are currently involved in establishing sig-
nal processing techniques and coronary artery microbruit
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interpretation tools that are expected to increase the diag-
nostic accuracy of these new acoustic sensors.
Correct classification of a patients risk for CAD with an
acoustic sensor or combination of clinical risk stratification
scores and acoustic sensor results may not only reduce
health expenses but also reduce the risk of complications
related to non-invasive imaging techniques and invasive
procedures.
Recently, the diagnostic accuracy of an acoustic sensor
(Cardiac Sonospectrographic Analyzer model 3,
SonoMedica, Virginia, United States) was reported to have
a sensitivity of 90 % and specificity of 58 % compared to
coronary computed tomographic angiography (CCTA) as
reference standard [3]. The area under the receiver oper-
ating characteristic curves (AUC) was 74 %, which is
similar or higher compared to clinical risk scorings systems
[4]. In a previous study, an early algorithm and a prototype
of an acoustic sensor were tested in a cohort of patient with
high risk of CAD using invasive coronary angiography
(ICA) as reference standard, and a diagnostic accuracy was
reported with a sensitivity of 71 %, specificity of 64 %,
and AUC of 77 % [5].
The primary aim of this study was to evaluate the
diagnostic accuracy of an acoustic sensor with an opti-
mized computerized algorithm and recording principle in a
large cohort of patient with symptoms suggestive of stable
angina pectoris. Secondarily, we compared the diagnostic
accuracy of the acoustic sensor to clinical risk stratification
with the updated Diamond–Forrester score, coronary artery
calcium score (CACS), and their combinations.
Materials and methods
Study design and patients
We prospectively enrolled patients referred for CCTA or
ICA as part of their evaluation of suspected obstructive
CAD. Patients were recruited consecutively at a single
center. Inclusion criteria were symptoms suggestive of
stable angina pectoris and age above 18 years. Exclusion
criteria were unstable angina pectoris or acute coronary
syndrome, arrhythmia including atrial fibrillation and
tachycardia higher than 85 bpm, known diastolic cardiac
murmur, left ventricle ejection fraction \50 %, previous
thoracic and cardiac surgery, severe chronic obstructive
lung disease or asthma with inability to perform a breath
hold for 8 s, active treatment for cancer or organ trans-
plantation, and pregnancy. The study was approved by the
Danish Data Protection Agency, the Central Denmark
Region Committees on Health Research Ethics, and fol-
lowed the principles in the declaration of Helsinki. Written
informed consent was obtained from all patients.
All patients were scheduled for (1) a clinical visit during
which an acoustic recording was obtained, (2) CACS, and
(3) CCTA or ICA. In the event of an abnormal CCTA,
patents were referred for myocardial perfusion imaging
with single-photon emission computed tomography
(99mTc-sestamibi) or positron emission tomography
(82Rb) and subsequently to ICA if myocardial ischemia
was detected (Fig. 1).
Clinical information was obtained through patient
interviews and reviews of medical records. Left ventricular
ejection fraction was evaluated by echocardiography.
The CAD-sore recording and algorithm
The acoustic sensor system recording site is the fourth left
intercostal space. The recording time is 3 min, and patients
were asked to hold their breath 4 times for 7.5 s (Fig. 2a).
The automatic algorithm identifies acoustic properties of
the diastolic heart sound statistically related to CAD. Initial
algorithms were aimed at identifying only weak high fre-
quency ([200 Hz) murmurs related to post stenotic tur-
bulence [6]. As a supplement, low frequency changes of
the diastolic heart sounds caused by CAD have also been
identified recently [7, 8]. The current CAD-score algorithm
combines high and low frequency measures into a com-
bined CAD-score.
The algorithm has two main parts: (1) a pre-processing
part, which identifies the mid diastolic heart sound periods
(the diastasis periods between the third and fourth heart
sounds) and filters out noise from the recordings and (2) the
part that estimates the CAD-score. In cases in which no S4
heart sounds were identified, the analyzing window was
ended 50 ms before the S1 sound. The CAD-score is based
on four measures (Fig. 2b):
• Frequency power ratio (FPR), which measures the low
frequency power in the mid diastolic heart sounds.
• Principle component analysis of the diastolic frequency
spectrum (PCASpec). This quantifies the complete
frequency spectrum from 20 to 1000 Hz into a single
measure.
• Auto-mutual information (AMI), which is a complexity
measure which previously has been used for successful
detection of CAD [9].
• The amplitude of the fourth heart sound (S4Amp). The
fourth heart sound is known as a weak predictor of
ischemic heart disease [10].
The four measures are combined into the CAD-score
using a standard linear discriminant score. The FPR and
PCASpec measures both require a signal interval at
128 ms; however, in some patients the diastasis interval,
the period between the third and fourth heart sounds, was
shorter than 128 ms. These cases were labeled patients
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with short diastasis, and the CAD-score was estimated
using only the AMI and S4 measures. The mean frequency
spectrums were only calculated in patients with a period
between the third and fourth heart sounds of more than
128 ms. The CAD-score ranges from 0 to 100 CAD-score
points.
Coronary computed tomography
Computed tomography scans were acquired using a dual-
source multidetector scanner (SOMATOM Definition
Flash, Siemens, Germany). All included patients under-
went a non-enhanced scan from which CACS were cal-
culated with the Agatston method [11].
Patients referred for CCTA subsequently underwent a
contrast-enhanced scan with prospective electrocardiogram
gating and dose modulation in the systolic or diastolic
phases depending on heart rate. Tube settings were
dependent on patient weight, and current modulation was
applied. Coronary images were reconstructed using raw
data iterative reconstruction. Oral and intravenous meto-
prolol was administrated to obtain a heart rate of\65 bpm
to optimizing CCTA images. The contrast media, Ioversol
(350 mg/ml), was utilized, and all patients received glyc-
erylnitrat (0.8 mg) sublingually just prior to the CTTA.
All coronary segments were analyzed according to
standard clinical practice with the use of commercially
available software (Syngo.via, Siemens, Germany). The
CCTA readers were permitted to use all the available post-
processing image reconstruction algorithms, including
axial images, multiplanar and curved reformation, maximal
intensity projection, volume-rendered techniques, and
cross-sectional area analysis. A semi-quantitative scale was
used to grade the extent of luminal diameter stenosis. The
stenosis severity was obtained in the following manner: no
stenosis: 0 % diameter reduction; mild to moderate steno-
sis: 1–49 % diameter reduction; and severe stenosis:
50–100 % diameter reduction. Abnormal CCTA results
were defined as a segment with a diameter greater than
2 mm and a more than 50 % reduction in luminal diameter.
CCTA with non-evaluable segments with a diameter
greater than 2 mm were also defined as abnormal. All
patients with an abnormal CCTA result were referred to a
myocardial perfusion imaging test or ICA, and obstructive
Fig. 1 Flow chart of patients in the study. Myocardial perfusion imaging (SPECT/PET), CAD Coronary artery disease
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CAD was diagnosed on the basis of these tests. No patients
or segments were excluded from the analysis.
Invasive coronary angiography
ICA was performed using standard techniques in a clini-
cal setting. The contrast media utilized was iodixanol
(350 mg/ml). Intracoronary nitroglycerin injection
(200 lg) was given prior to contrast injection. Coronary
segments with a reference diameter larger than 2 mm and
more than 30 % diameter stenosis were categorized as
having CAD (non-obstructive or obstructive). The seg-
ments with disease were visualized in multiple planes to
avoid overlapping of vessels, to minimize foreshortening,
and to obtain a perpendicular view of the stenosis for
further analysis. Quantitative coronary angiography
(QCA) was performed on all segments with disease.
Image frames were selected in the end-diastolic phase,
and manual edge correction was performed when needed.
Obstructive CAD was defined as more than 50 % diam-
eter stenosis by QCA. Dedicated QCA software (QAn-
gioXA 7.3, Medis, the Netherlands) was used for the
analysis and observers were blinded to risk score, CCTA
results, and CAD-score.
Statistical analysis
Gaussian distributed variables are expressed as mean
(±standard deviation (SD) or total range). Variables not
Gaussian distributed are presented as median (range).
Categorical variables are reported as frequencies (per-
centages). The unpaired Student’s t test and ANOVA test
were used for comparisons between Gaussian distributed
variables. Wilcoxon rank-sum (Mann–Whitney) test and
the Chi square (v2) test were used for comparisons between
non-Gaussian distributed and categorical variables,
respectively. Pearson and Spearman tests were used to
analyze correlations of variables of Gaussian and non-
Gaussian distributions, respectively. The area under the
receiver operating characteristic (AUC) curve was calcu-
lated for continues variables, and the optimal cut point was
established by the method described by Liu X [12]. Sen-
sitivity, specificity, positive and negative predictive values
(PPV and NPV), and positive and negative likelihood ratios
(PLR and NLR) were calculated for binary variables, with
quantitative ICA as reference. CAD-scores were divided as
a binary variable and into three levels: low (\20), inter-
mediate (20–30), and high ([30). Continuous net-reclas-
sification index (NRI) and integrated discrimination
Fig. 2 Schematic drawing of
the placement and 3-min
recording procedure with the
CAD-score acoustic sensor
system (a) and principle of the
automatic algorithm used to
calculate the CAD-score (b)
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Table 1 Table of baseline and the cardiac imaging characteristics in patients with non-CAD, non-obstructive CAD, and obstructive CAD
Non CAD Non-obstructive CAD Obstructive CAD
Patients 124 41 63
Patients characteristic
Age 58.9 ± 11.1 64.5 ± 9.4** 65.3 ± 9.2***
Gender (Male) 51 (41 %) 22 (54 %) 48 (76 %)***
BMI 27.4 ± 4.5 25.2 ± 2.8** 26.6 ± 4.0
Blood pressure
Systolic 137 ± 19 145 ± 20* 143 ± 18*
Diastolic 81 ± 10 82 ± 12 82 ± 11
Heart frequent 65 ± 9 67 ± 12 65 ± 10
Smoking *
Actively 28 (23 %) 8 (20 %) 11 (17 %)
Previous 41 (33 %) 13 (32 %) 37 (59 %)
None 54 (44 %) 19 (46 %) 15 (24 %)
Cholesterol
Total 5.1 ± 1.1 5.1 ± 1.2 5.0 ± 1.1
LDL 3.1 ± 1.0 3.0 ± 1.0 3.1 ± 1.1
HDL 1.5 ± 0.5 1.5 ± 0.4 1.4 ± 0.4
Triglycerides 1.4 ± 0.8 1.4 ± 0.8 1.7 ± 1.0
Diabetes 8 (6 %) 4 (10 %) 9 (14 %)
Previous percutaneous coronary intervention 1 (1 %) 5 (12 %)*** 17 (27 %)***
Type of symptoms ***
Non-cardiac chest pain 20 (16 %) 8 (20 %) 8 (13 %)
Atypical 70 (56 %) 19(46 %) 12 (19 %)
Typical 34 (27 %) 14 (34 %) 43 (68 %)
Diamond–Forrester score, mean 25 ± 17 34 ± 21** 51 ± 22***
Diamond–Forrester risk categories ** ***
Very low,\10 % 27 (22 %) 1 (2 %) 1 (2 %)
Low, C10 to\30 % 56 (45 %) 20 (49 %) 14 (22 %)
Moderate, C30 to\60 % 34 (27 %) 13 (32 %) 21 (33 %)
High, C60 % 7 (6 %) 7 (17 %) 27 (43 %)
Cardiac imaging characteristics
Left ventricle ejection fraction by echo 61 ± 4 60 ± 4 60 ± 3
Coronary artery calcium score, mean 64 ± 147 414 ± 465*** 1130 ± 1293***
Coronary artery calcium score groups *** ***
=0 70 (57 %) 2 (5 %) 2 (3 %)
[0 and\400 47 (38 %) 22 (54 %) 23 (38 %)
C400 6 (5 %) 17 (42 %) 36 (59 %)
Coronary vessel disease by ICA
1-Vessel disease NA NA 44 (70 %)
2-Vessel disease NA NA 14 (22 %)
3-Vessel disease or left main NA NA 5 (8 %)
Diseased vessel diameter by ICA#,
Diameter\ 3 mm NA NA 30 (%)
Diameter C 3 mm NA NA 32 (%)
Stenosis diameter reduction by ICA##
Stenosis C50 and\70 % NA NA 35 (56 %)
Stenosis C70 and\100 % NA NA 21 (33 %)
Stenosis = 100 % NA NA 7 (11 %)
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improvement (IDI) were tested for evaluating the benefit of
combining the Diamond-Forrester score and CAD-score.
Calculation of the categorical net-reclassification index
(NRI) was performed according to four predefined risk
categories: very low: \10 %, low: C10 to \30 %,
moderate: C30 to\60 %, and high: C60 %. All p-values
are two-sided with a 5 % level of significance. Statistical
analyses were performed using STATA, version 13.1
(StatCorp LP, United States), but NRI and IDI were cal-
culated using the R package PredictABEL [13]. To validate
the algorithm and avoid overfit to randomness in the
Table 1 continued
Non CAD Non-obstructive CAD Obstructive CAD
Stenosis by vessel
Stenosis in LM or LAD NA NA 33
Stenosis in CX NA NA 23
Stenosis in RCA NA NA 28
Data are missing in 3 patients and 1 patient. In the event of multivessel disease, the vessel with the largest diameter# and most severe vessel
diameter narrowing## was registered. Patients with multivessel disease are presented more than once
Statistical significance compared to the non-CAD group is showed in the table with: * if p\ 0.05; ** if p\ 0.01; *** if p\ 0.001
A
B
Fig. 3 Average diastolic frequency spectrum plots which show the
distribution of power across frequencies. Illustrated is the average
frequencies spectrums relation to different degrees of CAD (a) and
CACS scores (b). Included in the analysis are only patients with a
period between the third and fourth heart sounds of more than 128 ms
Fig. 4 Correlation between CAD-score and the updated Diamond-
Forrester score (a) and CAD-score and coronary artery calcium
scorende (b). Red dots mark patients with obstructive coronary artery
disease (n = 63), yellow dots patients with non-obstructive coronary
artery disease (n = 41), and green dots patients with non-coronary
artery disease (n = 124). The dashed line illustrates a CAD-score
cutoff at 20 and 30
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current heart sound recording, the linear discriminant
function, which combines the four features, was tested
using 20 times tenfold cross validation [14].
Results
We enrolled 255 patients in this study. Of these, 6 were
patients excluded due to the lack of a CAD-score or
angiography. Twenty-one patients were excluded due to
errors in the computerized algorithm registered as
arrhythmias (n = 7), recordings with excess noise
(n = 12) or the heart signal was too weak (n = 2). Of the
remaining 228 patients, 109 (48 %) patients were referred
to CCTA and 119 (52 %) to ICA (Fig. 1).
Based on the results of the CCTA and ICA, the patients
were grouped into non-CAD (n = 124), non-obstructive
CAD (n = 41), and obstructive CAD (n = 63) as
demonstrated in Fig. 1. Baseline and cardiac imaging
characteristic are listed in Table 1.
Comparing the sound power (dB) and frequency (Hz),
we saw a significant difference between the mean fre-
quency spectrums in patients with non-CAD compared to
patients with non-obstructive and obstructive CAD
(Fig. 3a). The mean CAD-score calculated from the fre-
quency spectrums was 21.3 ± 12.7 in the non-CAD group,
which was significantly low than the CAD-score in the
non-obstructive CAD group, 29.7 ± 11.8 (p\ 0.001) and
in the obstructive CAD group, 32.8 ± 10.8 (p\ 0.001).
There was a weak correlation between the CAD-score
and the Diamond–Forrester score, Pearson coeffi-
cient = 0.36 (p\ 0.001) (Fig. 4a). However, CAD-scores
increased in the non-obstructive CAD and obstructive CAD
groups compared to the non-CAD group even when
patients were divided into clinical risk stratification cate-
gories and CACS groups (Table 2).
Table 2 Table of mean CAD-scores according to CAD status
Non CAD Non-obstructive CAD Obstructive CAD
CAD-score, mean 21.3 ± 12.7 29.7 ± 11.8*** 32.8 ± 10.8***
Diamond-Forrester risk categories
Very low,\10 % 15.0 ± 9.2 33.6 ± NA 22.6 ± NA
Low, C10 to\30 % 21.9 ± 11.7 25.8 ± 11.6 34.1 ± 10.5***
Moderate, C30 to\60 % 23.4 ± 13.4 32.0 ± 10.3* 30.4 ± 9.9*
High, C60 % 30.6 ± 19.6 34.3 ± 11.6 34.3 ± 11.6*
Coronary artery calcium score groups
=0 20.9 ± 13.2 29.3 ± 16.0 41.3 ± 1.1*
[0 and\400 21.7 ± 12.7 31.6 ± 10.9** 33.1 ± 9.6***
C400 21.9 ± 6.3 27.1 ± 12.9 32.5 ± 11.6*
Invasive coronary angiography
Coronary vessel disease by ICA
1-vessel disease NA NA 32.6 ± 10.4
2-vessel disease NA NA 32.8 ± 11.7
3-vessel disease or left main NA NA 33.9 ± 13.4
Diseased vessel diameter by ICA#,
Diameter\ 3 mm NA NA 31.5 ± 9.5
Diameter C 3 mm NA NA 33.9 ± 12.0
Stenosis diameter reduction by ICA##
Stenosis C50 and\70 % NA NA 33.2 ± 10.5
Stenosis C70 and\100 % NA NA 33.1 ± 12.0
Stenosis = 100 % NA NA 29.5 ± 8.3
Stenosis by vessel
Stenosis in LM or LAD NA NA 31.4 ± 11.9
Stenosis in CX NA NA 35.4 ± 11.5
Stenosis in RCA NA NA 31.9 ± 8.3
Data are missing in 3 patients and 1 patient. In the event of multivessel disease, the vessel with the largest diameter# and most severe vessel
diameter narrowing## was registered. Patients with multivessel disease are presented more than once
Statistical significance compared to the non-CAD group is showed in the table with: * if p\ 0.05; ** if p\ 0.01; *** if p\ 0.001
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Similarly, the correlation between CAD-score and
CACS was weak, Spearman´s rho = 0.28 (p\ 0.001) and
the CAD-score increased significantly between the groups
in patients with CACS at 0, higher than 0 but lower than
400, and higher than 400 (Fig. 4b; Table 2). A significant
mean difference between the mean frequency spectrums
was also seen in patients with CACS 0, higher than 0 but
lower than 400, and higher than 400 (Fig. 3b).
There was no significant difference in CAD-score
between patients with single vessel obstructive CAD
compared to patients with multivessel obstructive CAD. In
addition, no differences in CAD-score were found between
patients with vessels with a reference lumen diameter lar-
ger than 3 mm compared to smaller than 3 mm or diameter
stenosis narrowing between 50 and 70 %, 70 and 99 %, or
100 % (Table 2). Five of the seven patients with a 100 %
occluded stenosis did not have other significant stenosis. In
these, the average CAD-score was 28.5, which is lower
than the average in the obstructive CAD group, but higher
than in the non-CAD group.
Diagnostic accuracy
The diagnostic accuracy of obstructive CAD vs. non-ob-
structive and non-CAD evaluated by AUC was for the CAD-
score, 72 % (CI 65–79 %),whichwas non-significantly lower
compared to the Diamond-Forrester Score, 79 % (CI
72–86 %) (p = 0.12) and significantly lower than CACS,
86 % (CI 81–91 %) (p\ 0.01). When the CAD-score and
Diamond-Forrester score were combined, AUC increased to
82 %(CI 76–88 %),whichwas significantly higher compared
to both standalone CAD-score (p\ 0.01) and the Diamond-
Forrester score (p\ 0.05). The combination of CAD-score
and the Diamond-Forrester Score was not significantly lower
than CACS alone (p = 0.28) (Fig. 5). There was a limited
benefit from combining CAD-score and the Diamond-For-
rester scorewithCACSor combining all three scores together,
AUC: 87 % (CI 82–92 %), 87 % (CI 82–92 %) and 89 % (CI
84–93 %), respectively. When the algorithm was adjusted
using the tenfold cross-validation scheme, the AUC was
70.5 %, which was close to the 72 % obtained by the final
CAD-score, indicating a low risk of overfitting.
The optimal CAD-score threshold for a binary predic-
tion of obstructive CAD was 24.2. Using this threshold, the
sensitivity, specificity, PPV, and NPV were 76 % (CI
64–86 %), 59 % (CI 52–67 %), 42 % (CI 33–51 %) and
87 % (CI 79–92 %), respectively.
A low CAD-score (B20) was observed in 62 (50 %)
non-CAD patients, 12 (29 %) non-obstructive CAD
patients, and 6 (10 %) CAD patients. An intermediate
score was observed in 37 (30 %) non-CAD patients, 6
(15 %) non-obstructive CAD patients and in 20 (32 %)
CAD patients. The remaining 25 (20 %) of the non-CAD
patients, 23 (56 %) of the non-obstructive CAD patients,
and 37 (59 %) CAD patients had a high CAD-score ([30).
NPV of a low CAD-score (B20) was 92.5 % (CI
87–98 %), and the PPV of a high CAD-score ([30) was
43.5 % (CI 33–54 %) when both non-CAD and non-ob-
structive CAD patients were considered healthy.
Continuous-NRI calculated for the diagnostic strategy of
adding CAD-score to the Diamond-Forrester score was
0.71 (CI 0.50–0.92) (p\ 0.001) and IDI was 0.09 (CI
0.04–0.14) (p\ 0.001). Categorical-NRI calculated for the
diagnostic strategy of adding the CAD-score to the Dia-
mond-Forrester score reclassified 18 patient with obstruc-
tive CAD to a higher risk category and 6 patients to a lower
risk category. Of patients without obstructive CAD, 55
patients were reclassified to a lower risk category and 36 to
a higher category. Categorical NRI was 0.31 (CI
0.12–0.49) (p\ 0.01) (Table 3).
In total, 70 (31 %) patients were classified in the very
low risk category with the diagnostic model including both
Diamond-Forrester score and CAD-score compared to 29
(13 %) patients with the Diamond-Forrester Score. The
disease prevalence in the very low risk category was 3 %
for both models. The combined diagnostic model classified
58 in the high risk category compared to 39 with the
Diamond-Forrester score, and the disease prevalence
decreased to 55 % from 64 %.
Discussion
The main finding in this study was that an acoustic sensor
providing the CAD-score seems to predict obstructive
CAD independent of the updated Diamond-Forrester score
Fig. 5 Receiver operating characteristic curve for CAD-score [or-
ange line, AUC: 72 % (CI 65–79)], Diamond-Forrester score [blue
line, AUC: 79 % (CI 72–86 %)], coronary artery calcium score [black
line, AUC: 86 % (CI 81–91 %)] and the combined Diamond-
Forrester score and CAD-score [purple line, AUC 82 % (CI
76–88 %)]. The grey dash line is the reference line
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and CACS in patients presenting with symptoms sugges-
tive of stable angina pectoris. We demonstrated an additive
diagnostic accuracy when combining the Diamond-For-
rester score and the CAD-score. Of particular interest, the
high number of patients reclassified to the very low risk
category indicates the clinical potential of this novel
diagnostic method in primary risk stratification before non-
invasive and invasive coronary diagnostic procedures.
Acoustic sensor and algorithm
The acoustic CAD-score is based on heart sound recordings
obtained with an ultra-sensitive microphone and a novel
signal-processing algorithm. The novelty of the algorithm
is the combination of information from both the low and
high frequency parts of the diastolic heart sounds. The high
frequency feature quantifies high frequency microbruits,
which are expected to occur at frequencies above 200 Hz
[6]. However Fig. 4a demonstrates a significant drop in
absolute frequencies above approximately 500 Hz, which
may indicate that the diastolic energy concentrates at lower
frequencies below 500 Hz. However the microbruits are of
low amplitude, and the variation in absolute power across
subjects is large, therefore the microbruits might very well
be buried in the absolute frequency spectrums. The sig-
nificant increase in power below 150 Hz, see Fig. 4a, is in
Table 3 Table of the risk stratification with updated Diamond–Forrester score (DF-score) and with the combined model of Diamond–Forrester
score and CAD-score
Prevalence of CAD in a model combining DF-score and CAD-score Total
\10 % C10 to\30 % C30 to\60 % C60 %
Numbers of patients and prevalence of CAD (%)
DF-score:\10 % 26 (4 %) 3 (0 %) 0 (0 %) 0 (0 %) 29 (3 %)
DF-score: C10 to\30 % 34 (0 %) 31 (19 %) 25 (32 %) 0 (0 %) 90 (16 %)
DF-score: C30 % to\60 % 10 (10 %) 11 (18 %) 21 (38 %) 26 (38 %) 68 (31 %)
DF-score: C60 % 0 (0 %) 4 (50 %) 2 (50 %) 35 (69 %) 41 (66 %)
Total 70 (3 %) 49 (20 %) 48 (35 %) 61 (56 %) 228
Obstructive CAD
DF-score:\10 % 1 0 0 0 1
DF-score:C10 to\30 % 0 6 8 0 14
DF-score: C30 to\60 % 1 2 8 10 21
DF-score: C60 % 0 2 1 24 27
Total 2 10 17 34 63
Non or non-obstructive CAD
DF-score:\10 % 25 3 0 0 28
DF-score: C10 to\30 % 34 25 17 0 76
DF-score: C30 to\60 % 9 9 13 16 47
DF-score: C60 % 0 2 1 11 14
Total 68 39 31 27 165
Net-reclassification index—categorical
Obstructive CAD patients
Classified upward: 18 (29 %)
Classified downward: 6 (10 %)
Classified into a more relevant risk class: 18 – 6 = 12 (19 %)
Non or non-obstructive CAD patients:
Classified upward: 36 (22 %)
Classified downward: 55 (33 %)
Classified into a more relevant risk class: 55 – 36 = 20 (12 %)
Calculation of categorical net-reclassification index
Patients in total, classified into a more relevant risk class: 19 % ? 12 % = 31 % (p B 0.01)
Reclassification of patients with the combined model Diamond–Forrester score and CAD-score is showed compared to Diamond–Forrester score
alone, and categorical net-reclassification index is calculated
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line with recent findings [7, 8]. The cause of the increased
diastolic heart sound pressure at lower frequencies is
unknown, but the low frequency sound is likely due to
oscillations in the myocardium. These oscillations might
occur due to altered diastolic filling patterns or changes in
resonate frequencies of the coronary artery system due to
stiffening of the arteries.
The diagnostic performance of the acoustic CAD-score
is in line with the performance (AUC 74.3 %) reported by
Makaryus AN et al. [3] of the Cardiac Sonospectrographic
Analyzer. However, contradictory to the Cardiac
Sonospectrographic Analyzer, the current system is based
on a single recording from a recording site at the 4th
intercostal room, which may simplify the use of the system.
Diagnostic accuracy
In the present study we compared the diagnostic accuracy
of the acoustic CAD-score to a simple clinical risk strati-
fication score based on age, gender, and type of chest
symptoms. As a standalone test, the CAD-score performed
as well as the updated Diamond-Forrester score. However,
a significantly increased diagnostic accuracy was detected
when combining the two scores. This is an improvement
over the lack of increased diagnostic accuracy by adding
more advance clinical risk scores, such as the Duke risk
score (based on sex, age, diabetes, tobacco use, history of
myocardial infarction, and symptoms of angina pectoris) or
Morise risk score (based on sex, age, diabetes, tobacco use,
symptoms of angina pectoris, hypercholesterolemia,
hypertension, family history of CAD, obesity, and estrogen
status) [4, 15, 16].
CACS has in previous studies demonstrated high diag-
nostic accuracy of CAD when evaluated by AUC. Inter-
estingly, we only found a weak correlation between the
CACS and the CAD-score. This finding is similar to the
correlation between CACS and results obtained by the
Cardiac Sonospectrographic Analyzer [3]. This may indi-
cate that acoustic tests of CAD measures coronary stenosis
severity rather than artery wall stiffness.
The simple and non-invasive method without contrast
or radiation exposure described here seems to be an
attractive approach to risk stratification of patients with
symptoms suggestive of stable angina pectoris. Nonethe-
less, our study demonstrated only moderate diagnostic
accuracy of this novel test as standalone modality. Inter-
estingly, a high negative predictive value of a low CAD-
score value (B20) indicated a potential as a rule-out
device. Thus, as add-on to clinical risk stratification,
diagnosis of CAD by sound analysis from coronary
stenosis-induced turbulent blood flow may have a clinical
role, e.g. in primary care settings.
Limitations
Since the CAD-score is based on diastolic heart sounds,
subjects with diastolic murmurs were not included in the
study. This means that auscultation before estimating the
CAD-score is required to rule out diastolic murmurs due to
valvular heart disease. Data from the current study popu-
lation were used for both development and validation of the
acoustic CAD-score. This implies a risk of overfitting the
algorithm to the current population. To minimize this risk,
the cross-validation was applied and showed similar per-
formance results, indicating a low risk of overfitting.
However, further validation in a prospective study has to be
performed to confirm the current findings.
Conclusion
This study demonstrates the potential use of a non-inva-
sive, non-radiation acoustic detection system to identify
coronary artery disease. The combination of clinical risk
scores and an acoustic test seems to optimize patient
selection for diagnostic investigation.
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